P713 Home-based vedolizumab infusions: A suitable alternative to routine hospital infusions

Peek-Kuijt, N.; Nieuwstraten, Jelle A.; Ginkel, Leendert van; Maljaars, Jeroen; Jong, A van der Meulen de

doi:10.1093/ecco-jcc/jjx180.840

Cited by 2 publications

(4 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Considerations for specialty medications for home administration. [92][93][94][95][96][97][98][99][100][101][102][103] Therapy and current practice…”

Section: Discussionmentioning

confidence: 99%

“…One-hour infusions will conserve health care resources and may lead to improved adherence and quality of life in patients. Vedolizumab 100,101 Home infusion…”

Section: Golimumab 95 Ustekinumab 96mentioning

confidence: 99%

“…92,93 Table 4 provides a comprehensive list of specialty medications that have been shown to be safe via home delivery. [92][93][94][95][96][97][98][99][100][101][102][103]…”

Section: Specialty Infusion (Non-oncology Indications)mentioning

confidence: 99%

“…Considerations for specialty medications for home administration. [92][93][94][95][96][97][98][99][100][101][102][103] Manufacturer provides patient education sheet for home injections https://cimzia.com/injection-training. .…”

mentioning

confidence: 99%

See 3 more Smart Citations

Clinical strategies for optimizing infusion center care through a pandemic

Hanna

Segal

Barlow

et al. 2020

J Oncol Pharm Pract

View full text Add to dashboard Cite

The national pandemic resulting from the novel coronavirus, COVID-19, has made the delivery of care for patients with cancer a challenge. There are competing risks of mortality from cancer versus serious complications and higher risk of death from COVID-19 in immunocompromised hosts. Furthermore, compounding these concerns is the inadequate supply of personal protective equipment, decreased hospital capacity, and paucity of effective treatments or vaccines to date for COVID-19. Guidance measures and recommendations have been published by national organizations aiming to facilitate the delivery of care in a safe and effective manner, many of which, are permanently adoptable interventions. Given the critical importance to continue chemotherapy, there remains additional interventions to further enhance patient safety while conserving healthcare resources such as adjustments in medication administration, reduction in laboratory or drug monitoring, and home delivery of specialty infusions. In this manuscript, we outline how to implement these actionable interventions of chemotherapy and supportive care delivery to further enhance the current precautionary measures while maintaining safe and effective patient care. Coupled with current published standards, these strategies can help alleviate the numerous challenges associated with this pandemic.

show abstract

“…Considerations for specialty medications for home administration. [92][93][94][95][96][97][98][99][100][101][102][103] Therapy and current practice…”

Section: Discussionmentioning

confidence: 99%

“…One-hour infusions will conserve health care resources and may lead to improved adherence and quality of life in patients. Vedolizumab 100,101 Home infusion…”

Section: Golimumab 95 Ustekinumab 96mentioning

confidence: 99%

“…92,93 Table 4 provides a comprehensive list of specialty medications that have been shown to be safe via home delivery. [92][93][94][95][96][97][98][99][100][101][102][103]…”

Section: Specialty Infusion (Non-oncology Indications)mentioning

confidence: 99%

mentioning

confidence: 99%

See 2 more Smart Citations